HIV Archives
Researchers study unique couples intervention in Mozambique to reduce HIV transmission
Aug. 3, 2017—Researchers in the Vanderbilt Institute for Global Health are testing whether a unique “couples-centered” intervention developed in the southern African nation of Mozambique can reduce mother-to-child transmission of HIV.
HIV-infected people have higher risk of heart failure
Apr. 27, 2017—The first large study to report that HIV-infected people have a significantly higher risk of heart failure in the antiretroviral therapy era has been published in JAMA Cardiology.
Blood exposures for traditional healers
Sep. 23, 2016—Traditional healers in sub-Saharan have a high rate of exposure to blood, putting them at risk for HIV and hepatitis C.
HIV treatment and TB risk
Aug. 4, 2016—Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV).
First subject enrolled in international HIV prevention study
Apr. 14, 2016—This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.
Potent HIV antibodies suggest new vaccine development approach
Apr. 7, 2016—It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks.
Study explores gene’s role in protecting HIV patients from TB
Mar. 17, 2016—An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.
Depression poses heart risk for HIV patients: study
Oct. 8, 2015—The first study to suggest that major depressive disorder (MDD) is an independent risk factor for heart failure in HIV-positive adults has been published in Circulation.
Grants bolster HIV-focused research capacity
Aug. 20, 2015—The Vanderbilt Institute for Global Health (VIGH) has received two new grants from the Fogarty International Center of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Zambia, Mozambique and Brazil.
VUMC, Meharry and State Health Department receive NIH grant to establish AIDS research center
Jun. 25, 2015—Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health.
New strategy to combat HIV
Jun. 12, 2015—Inhibitors of the enzyme phospholipase D1 suppress the replication of HIV-1, Vanderbilt investigators have discovered.
‘Redesigned’ antibodies may control HIV: study
May. 21, 2015—With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.
